(Q51550685)

6 April 2018

title

Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus. (English)

1 reference

6 April 2018

1 reference

1 reference

1 reference

1 reference

1 reference

López-Alvarenga JC

1

1 reference

6 April 2018

Aguilar-Salinas CA

2

1 reference

6 April 2018

Velasco-Perez ML

3

1 reference

6 April 2018

Arita-Melzer O

4

1 reference

6 April 2018

Guillen LE

5

1 reference

6 April 2018

Wong B

6

1 reference

6 April 2018

Brito G

7

1 reference

6 April 2018

Mercado V

8

1 reference

6 April 2018

Gómez-Pérez FJ

9

1 reference

6 April 2018

Rull-Rodrigo JA

10

1 reference

6 April 2018

publication date

1 January 1999

1 reference

6 April 2018

Diabetes, Obesity and Metabolism

published in

1 reference

6 April 2018

volume

1

1 reference

6 April 2018

issue

1

1 reference

6 April 2018

page(s)

29-35

1 reference

6 April 2018

Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Acarbose: a review of US clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Standardization of IVGTT to predict IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Insulin therapy in maturity-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Combination therapy with insulin and sulfonylureas for type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

The two-period crossover design in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00007.X

10.1046/J.1463-1326.1999.00007.X

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018